Najmiatul Fitria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Najmiatul Fitria has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Yelly Oktavia Sari
Associate Professor. Department of Pharmacology and Clinical Pharmacy. Faculty of Pharmacy. Universitas Andalas. Padang. Indonesia
4 shared publications- Hansen Nasif
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Andalas, Padang, Indonesia
3 shared publications Yolanda Zazna Syaputri
3 shared publicationsAfifah Machlaurin
2 shared publicationsDian Ayu Juwita
Universitas Andalas
2 shared publicationsDita Permatasari
Department of Pharmacology and Clinical Pharmacy. Faculty of Pharmacy. Universitas Andalas
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 25
Depression, Medication Adherence, and Beliefs as Determinants of Health-Related Quality of Life among People Living with HIV: A Cross-Sectional Pharmacoepidemiologic Study in Indonesia
Objective: To examine the associations of depression, medication adherence, and medication beliefs with HRQoL among people living with HIV (PLWH) in primary healthcare (PHC) settings in Indonesia. Methods: This cross-sectional study included PLWH attending 6 PHCs in Makassar (July-September 2025). HRQoL was assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L); depression using the Patient Health Questionnaire-9 (PHQ-9); adherence using the Medication Adherence Report Scale (MARS); and beliefs using the Beliefs about Medicines Questionnaire (BMQ). Multivariable linear regression examined associations with HRQoL. Results: Among 400 participants (median age 30 years, interquartile range: 11), mean EQ-5D-5L utility was 0.94 ± 0.10. Higher depression severity was associated with lower HRQoL (β=−0.006; P < .001), while adherence and beliefs were not significant after adjustment. Conclusion: Depression was the only independent psychosocial predictor of HRQoL, highlighting the need for integrated mental health support in HIV care within PHC settings.
- 1 January 2026
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 25
Open AccessDepression, Medication Adherence, and Beliefs as Determinants of Health-Related Quality of Life among People Living with HIV: A Cross-Sectional Pharmacoepidemiologic Study in Indonesia
Objective: To examine the associations of depression, medication adherence, and medication beliefs with HRQoL among people living with HIV (PLWH) in primary healthcare (PHC) settings in Indonesia. Methods: This cross-sectional study included PLWH attending 6 PHCs in Makassar (July-September 2025). HRQoL was assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L); depression using the Patient Health Questionnaire-9 (PHQ-9); adherence using the Medication Adherence Report Scale (MARS); and beliefs using the Beliefs about Medicines Questionnaire (BMQ). Multivariable linear regression examined associations with HRQoL. Results: Among 400 participants (median age 30 years, interquartile range: 11), mean EQ-5D-5L utility was 0.94 ± 0.10. Higher depression severity was associated with lower HRQoL (β=−0.006; P < .001), while adherence and beliefs were not significant after adjustment. Conclusion: Depression was the only independent psychosocial predictor of HRQoL, highlighting the need for integrated mental health support in HIV care within PHC settings.
- Open Access
- 7 December 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 33-37
EFFECT OF IRON–FOLIC ACID SUPPLEMENTATION ON NUTRITIONAL STATUS: MID-UPPER ARM CIRCUMFERENCE AND BODYWEIGHT CHANGES DURING PREGNANCY
Objective: Chronic energy deficiency is a common condition among pregnant women and can adversely affect both maternal and fetal outcomes. Iron and folic acid (IFA) supplementation is routinely provided in maternal health services to prevent anemia and improve nutritional status. This study aimed to investigate the effect of IFA supplementation on maternal nutritional indicators, including changes in mid-upper arm circumference (MUAC), bodyweight, and prenatal body mass index (BMI) among pregnant women at the Lubuk Buaya Public Health Center in Padang. Method: A descriptive retrospective design was employed using medical records of 976 pregnant women from January to December 2024. Variables included the number of IFA tablets consumed, MUAC, bodyweight change, and prenatal BMI. Data were analyzed using the Compare Means test. Results: Statistical analysis showed that changes in MUAC were small and not clinically significant, despite a formally significant p-value (p=0.000). This likely reflects the absence of MUAC improvement rather than a beneficial effect of supplementation. For bodyweight, the largest group (30 tablets, n=926) showed no measurable change, while smaller groups receiving higher IFA doses (≥60 tablets) showed variable weight reductions, though very small sample sizes limited interpretation. Prenatal BMI was comparable across groups with no significant differences (p=0.183). The unequal distribution of participants, particularly the small number in the 90- and 120-tablet groups, limited statistical power and generalizability. Conclusion: Regular IFA supplementation was associated with improved MUAC, indicating benefits for maternal nutritional status, although effects on bodyweight and BMI were inconclusive due to sample imbalance and variability. Strengthening health education and encouraging adherence to antenatal visits are essential to ensure adequate supplementation and optimize maternal health outcomes.
- 7 December 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 33-37
Open AccessEFFECT OF IRON–FOLIC ACID SUPPLEMENTATION ON NUTRITIONAL STATUS: MID-UPPER ARM CIRCUMFERENCE AND BODYWEIGHT CHANGES DURING PREGNANCY
Objective: Chronic energy deficiency is a common condition among pregnant women and can adversely affect both maternal and fetal outcomes. Iron and folic acid (IFA) supplementation is routinely provided in maternal health services to prevent anemia and improve nutritional status. This study aimed to investigate the effect of IFA supplementation on maternal nutritional indicators, including changes in mid-upper arm circumference (MUAC), bodyweight, and prenatal body mass index (BMI) among pregnant women at the Lubuk Buaya Public Health Center in Padang. Method: A descriptive retrospective design was employed using medical records of 976 pregnant women from January to December 2024. Variables included the number of IFA tablets consumed, MUAC, bodyweight change, and prenatal BMI. Data were analyzed using the Compare Means test. Results: Statistical analysis showed that changes in MUAC were small and not clinically significant, despite a formally significant p-value (p=0.000). This likely reflects the absence of MUAC improvement rather than a beneficial effect of supplementation. For bodyweight, the largest group (30 tablets, n=926) showed no measurable change, while smaller groups receiving higher IFA doses (≥60 tablets) showed variable weight reductions, though very small sample sizes limited interpretation. Prenatal BMI was comparable across groups with no significant differences (p=0.183). The unequal distribution of participants, particularly the small number in the 90- and 120-tablet groups, limited statistical power and generalizability. Conclusion: Regular IFA supplementation was associated with improved MUAC, indicating benefits for maternal nutritional status, although effects on bodyweight and BMI were inconclusive due to sample imbalance and variability. Strengthening health education and encouraging adherence to antenatal visits are essential to ensure adequate supplementation and optimize maternal health outcomes.
- Open Access
- 30 November 2025
- Published by Universitas Andalas in Jurnal Sains Farmasi & Klinis
- Vol. 12 (2) , 138-144
Cost-Effectiveness of ACTH vs. ACT Chemotherapy Regimens at RSUP Dr. M. Djamil
Introduction: Breast cancer is one of the most common cancers and is often diagnosed at a late stage, especially in Indonesia. This highlights the need for cost-effective treatment options. ACT (Adriamycin, Cyclophosphamide, and Taxane) and ACTH (ACT plus Herceptin/Trastuzumab) are used chemotherapy regimens, but studies comparing their cost-effectiveness are still limited. This study aimed to evaluate the cost-effectiveness of ACT versus ACTH for breast cancer treatment using tumor volume reduction. Method: A retrospective cost-effectiveness study was carried out at Dr. M. Djamil Hospital by comparing direct medical costs and tumor volume changes in breast cancer patients treated with ACT or ACTH regimens. Effectiveness was based on the average change in tumor volume, and cost-effectiveness was evaluated using the Incremental Cost-Effectiveness Ratio (ICER). Results: The mean tumor volume reduction in the ACT group was 2820.85 ± 11190.42 cm³, and significantly higher at 9273.50 ± 60101.33 cm³ in ACTH, although the difference was not statistically significant (p = 0.614). The average direct medical cost for ACTH was IDR 67,138,579, compared to IDR 13,005,027 for ACT. The ICER calculation resulted in IDR-838,935 per cm³ of tumor reduction, while the negative ICER might suggest cost savings, it does not imply that ACTH is a dominant strategy indicating that ACTH incurred a higher cost with less effectiveness per unit of tumor reduction than ACT. Conclusion: The high associated cost leads to a negative ICER, suggesting that ACT may be more cost-effective in this setting. These findings are critical for optimizing chemotherapy choices within limited healthcare budgets.
- 30 November 2025
- Published by Universitas Andalas in Jurnal Sains Farmasi & Klinis
- Vol. 12 (2) , 138-144
Open AccessCost-Effectiveness of ACTH vs. ACT Chemotherapy Regimens at RSUP Dr. M. Djamil
Introduction: Breast cancer is one of the most common cancers and is often diagnosed at a late stage, especially in Indonesia. This highlights the need for cost-effective treatment options. ACT (Adriamycin, Cyclophosphamide, and Taxane) and ACTH (ACT plus Herceptin/Trastuzumab) are used chemotherapy regimens, but studies comparing their cost-effectiveness are still limited. This study aimed to evaluate the cost-effectiveness of ACT versus ACTH for breast cancer treatment using tumor volume reduction. Method: A retrospective cost-effectiveness study was carried out at Dr. M. Djamil Hospital by comparing direct medical costs and tumor volume changes in breast cancer patients treated with ACT or ACTH regimens. Effectiveness was based on the average change in tumor volume, and cost-effectiveness was evaluated using the Incremental Cost-Effectiveness Ratio (ICER). Results: The mean tumor volume reduction in the ACT group was 2820.85 ± 11190.42 cm³, and significantly higher at 9273.50 ± 60101.33 cm³ in ACTH, although the difference was not statistically significant (p = 0.614). The average direct medical cost for ACTH was IDR 67,138,579, compared to IDR 13,005,027 for ACT. The ICER calculation resulted in IDR-838,935 per cm³ of tumor reduction, while the negative ICER might suggest cost savings, it does not imply that ACTH is a dominant strategy indicating that ACTH incurred a higher cost with less effectiveness per unit of tumor reduction than ACT. Conclusion: The high associated cost leads to a negative ICER, suggesting that ACT may be more cost-effective in this setting. These findings are critical for optimizing chemotherapy choices within limited healthcare budgets.
- Open Access
- 24 October 2025
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 23 (3) , 1-9
Long-Term Impact of Pillbox Use on Medication Adherence in Patients with Type 2 Diabetes Mellitus
Background: This follow-up study assessed the long-term impact of pillbox use on medication adherence in type 2 diabetes mellitus (T2DM) patients over two years. Method: A cross-sectional study consisting of 52 participants was divided into two groups: pillbox (intervention) and non-pillbox (control). Adherence was measured using the pill count method, and clinical outcomes such as blood glucose levels were recorded. Results: Results revealed that the pillbox group had significantly higher adherence rates over time, with adherence increasing from 94.01% initially to 96.67% after two years. In contrast, adherence in the non-pillbox group declined from 88.62% to 88.26%. Postprandial blood glucose control improved significantly in the pillbox group (141.38 mg/dl to 129.88 mg/dl), whereas the non-pillbox group experienced an increase (137.96 mg/dl to 145.69 mg/dl). Fasting and random blood glucose levels did not show statistically significant changes. The analysis identified education and occupation as important predictors of adherence, while factors such as age, gender, comorbidities, and medication changes showed marginal or non-significant effects. Conclusion: These findings suggest that pillbox interventions can effectively improve long-term medication adherence and postprandial blood glucose control in T2DM patients, particularly when considering sociodemographic factors like education and occupation. Further research should explore the broader implications of these findings for diabetes management and potential strategies to improve adherence in diverse patient populations.
- 24 October 2025
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 23 (3) , 1-9
Open AccessLong-Term Impact of Pillbox Use on Medication Adherence in Patients with Type 2 Diabetes Mellitus
Background: This follow-up study assessed the long-term impact of pillbox use on medication adherence in type 2 diabetes mellitus (T2DM) patients over two years. Method: A cross-sectional study consisting of 52 participants was divided into two groups: pillbox (intervention) and non-pillbox (control). Adherence was measured using the pill count method, and clinical outcomes such as blood glucose levels were recorded. Results: Results revealed that the pillbox group had significantly higher adherence rates over time, with adherence increasing from 94.01% initially to 96.67% after two years. In contrast, adherence in the non-pillbox group declined from 88.62% to 88.26%. Postprandial blood glucose control improved significantly in the pillbox group (141.38 mg/dl to 129.88 mg/dl), whereas the non-pillbox group experienced an increase (137.96 mg/dl to 145.69 mg/dl). Fasting and random blood glucose levels did not show statistically significant changes. The analysis identified education and occupation as important predictors of adherence, while factors such as age, gender, comorbidities, and medication changes showed marginal or non-significant effects. Conclusion: These findings suggest that pillbox interventions can effectively improve long-term medication adherence and postprandial blood glucose control in T2DM patients, particularly when considering sociodemographic factors like education and occupation. Further research should explore the broader implications of these findings for diabetes management and potential strategies to improve adherence in diverse patient populations.
- Open Access
- 7 October 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 184-187
EXPLORING THE IMPACT OF PILLBOX USABILITY ON ADHERENCE AND GLYCEMIC REGULATION IN PRIMARY CARE SETTING WITH TYPE 2 DIABETES MELLITUS SYOFYAN
Objectives: Type 2 diabetes mellitus (T2DM) needs continuing adherence and effective self-management strategies to achieve optimal glycemic control. This investigation sought to explore the link between pillbox usability and patient adherence, patient adherence, and random blood glucose (RBG) levels, in addition to pillbox usability and RBG levels in T2DM. Methods: This observational study involved 33 patients with T2DM receiving care from the Lubuk Kilangan Primary Health Center, selected through purposive sampling. Pillbox usability was assessed using the System Usability Scale questionnaire, medication adherence was measured over a monthly period using the pill count method, and RBG data were obtained from patients’ clinical records. Data were analyzed using Spearman’s rank correlation test to consider relationships between variables. Results: The findings indicated no significant correlation between pillbox usability and either medication adherence or RBG levels (p>0.05). However, a significant negative link existed between medication adherence and RBG levels, with moderate strength (r=−0.456; P=0.008). Conclusion: These findings point to improved medication adherence contributing to better glycemic control, as indicated by lower RBG levels. Nevertheless, pillbox usability was not found to have a significant impact on either adherence or blood glucose control.
- 7 October 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 184-187
Open AccessEXPLORING THE IMPACT OF PILLBOX USABILITY ON ADHERENCE AND GLYCEMIC REGULATION IN PRIMARY CARE SETTING WITH TYPE 2 DIABETES MELLITUS SYOFYAN
Objectives: Type 2 diabetes mellitus (T2DM) needs continuing adherence and effective self-management strategies to achieve optimal glycemic control. This investigation sought to explore the link between pillbox usability and patient adherence, patient adherence, and random blood glucose (RBG) levels, in addition to pillbox usability and RBG levels in T2DM. Methods: This observational study involved 33 patients with T2DM receiving care from the Lubuk Kilangan Primary Health Center, selected through purposive sampling. Pillbox usability was assessed using the System Usability Scale questionnaire, medication adherence was measured over a monthly period using the pill count method, and RBG data were obtained from patients’ clinical records. Data were analyzed using Spearman’s rank correlation test to consider relationships between variables. Results: The findings indicated no significant correlation between pillbox usability and either medication adherence or RBG levels (p>0.05). However, a significant negative link existed between medication adherence and RBG levels, with moderate strength (r=−0.456; P=0.008). Conclusion: These findings point to improved medication adherence contributing to better glycemic control, as indicated by lower RBG levels. Nevertheless, pillbox usability was not found to have a significant impact on either adherence or blood glucose control.
- Open Access
- 1 June 2025
- Published by Negah Scientific Publisher in Iranian Rehabilitation Journal
- Vol. 23 (2) , 183-190
Individuals’ Quality of Life Affected by Pulmonary Tuberculosis in and After Intensive Rehabilitation Therapy
Objectives: Since pulmonary tuberculosis (TB) treatment takes at least six months, it affects TB patients’ quality of life (QoL). This study aimed to describe the QoL of individuals affected by pulmonary TB during the initial and post-intensive treatment phases. Methods: This cross-sectional study included 40 patients with TB in Padang ...
- 1 June 2025
- Published by Negah Scientific Publisher in Iranian Rehabilitation Journal
- Vol. 23 (2) , 183-190
Open AccessIndividuals’ Quality of Life Affected by Pulmonary Tuberculosis in and After Intensive Rehabilitation Therapy
Objectives: Since pulmonary tuberculosis (TB) treatment takes at least six months, it affects TB patients’ quality of life (QoL). This study aimed to describe the QoL of individuals affected by pulmonary TB during the initial and post-intensive treatment phases. Methods: This cross-sectional study included 40 patients with TB in Padang ...
- Open Access
- 24 February 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 101-106
AN RINVR SCORING EVALUATION OF ONDANSETRON, DEXAMETHASONE, AND RANITIDINE AS ANTIEMETICS IN BREAST CANCER CHEMOTHERAPY
Objective: Antiemetics is used to control Chemotherapy-Induced Nausea and Vomiting (CINV) in breast cancer patients undergoing ACTH (Adriamycin, Cyclophosphamide, Docetaxel, Herceptin) chemotherapy. This study aimed to assess the effectiveness of an antiemetic regimen consisting of Ondansetron, Dexamethasone, and Ranitidine combination using (Rhodes Index Nausea Vomiting and Retching) RINVR scoring. Additionally, to evaluate the difference in CINV incidence in ACTH cycles. Methods: A prospective cross-sectional study was conducted from March to June 2024 at Dr. M. Djamil. General Hospital Padang. The study determined the effect of antiemetic administration at the measurement time of 12 h, 24 h, 48 h, 72 h, and 96 h after chemotherapy. There were 30 respondents who met the inclusion criteria in this study. The instrument RINVR (Rhodes Index Nausea Vomiting and Retching) measured the vomit and nausea incidence. Results: There were differences in the incidence of emesis between ACH dan TH cycles at measurement times of 12 h, 48 h, and 72 h (p-value<0.05). The effect of antiemetic administration showed significant results in the 48 h ACH cycle, which indicates that the higher the cycle, the lower the RINVR score. Conclusion: The administration of antiemetics was notably effective at the 48 h mark in the ACH cycle, demonstrating a correlation between higher chemotherapy cycles and lower RINVR scores. These findings highlight the importance of tailored antiemetic strategies to improve patients' comfort and treatment outcomes.
- 24 February 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 101-106
Open AccessAN RINVR SCORING EVALUATION OF ONDANSETRON, DEXAMETHASONE, AND RANITIDINE AS ANTIEMETICS IN BREAST CANCER CHEMOTHERAPY
Objective: Antiemetics is used to control Chemotherapy-Induced Nausea and Vomiting (CINV) in breast cancer patients undergoing ACTH (Adriamycin, Cyclophosphamide, Docetaxel, Herceptin) chemotherapy. This study aimed to assess the effectiveness of an antiemetic regimen consisting of Ondansetron, Dexamethasone, and Ranitidine combination using (Rhodes Index Nausea Vomiting and Retching) RINVR scoring. Additionally, to evaluate the difference in CINV incidence in ACTH cycles. Methods: A prospective cross-sectional study was conducted from March to June 2024 at Dr. M. Djamil. General Hospital Padang. The study determined the effect of antiemetic administration at the measurement time of 12 h, 24 h, 48 h, 72 h, and 96 h after chemotherapy. There were 30 respondents who met the inclusion criteria in this study. The instrument RINVR (Rhodes Index Nausea Vomiting and Retching) measured the vomit and nausea incidence. Results: There were differences in the incidence of emesis between ACH dan TH cycles at measurement times of 12 h, 48 h, and 72 h (p-value<0.05). The effect of antiemetic administration showed significant results in the 48 h ACH cycle, which indicates that the higher the cycle, the lower the RINVR score. Conclusion: The administration of antiemetics was notably effective at the 48 h mark in the ACH cycle, demonstrating a correlation between higher chemotherapy cycles and lower RINVR scores. These findings highlight the importance of tailored antiemetic strategies to improve patients' comfort and treatment outcomes.
- Open Access
- 7 February 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 43-48
THE ROLE OF IRON FOLIC ACID AND MULTIPLE MICRONUTRIENTS IN TYPE OF CHILDBIRTH DELIVERY: ECONOMIC AND HEALTH IMPLICATION
Objective: Pregnancy is a critical period that can pose nutritional challenges, such as chronic energy deficiency and anemia, increasing maternal mortality risk. The World Health Organization recommends iron and folic acid supplements to mitigate these risks. This study compared labor types and associated costs between iron-folic acid (IFA) and multiple micronutrient (MMN) supplementations during pregnancy. Methods: An economic evaluation was conducted retrospectively at Semen Padang Hospital, analyzing data from January to December 2021. A total of 201 pregnant women were included, with 128 undergoing cesarean delivery. Cost data were collected from the hospital’s perspective and analyzed to identify differences between supplementation groups. Results: Total direct costs did not differ significantly between the IFA and MMN groups (p=0.82). However, medical costs varied substantially, with cesarean delivery costs being approximately 5 times higher than normal delivery costs. Conclusion: This study emphasizes the economic burden of cesarean deliveries compared to normal births and highlights the need for further evaluation of micronutrient supplementation’s cost-effectiveness. Findings advocate for policies that optimize maternal health outcomes and reduce delivery-related costs, addressing the high incidence of elective cesarean sections.
- 7 February 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 43-48
Open AccessTHE ROLE OF IRON FOLIC ACID AND MULTIPLE MICRONUTRIENTS IN TYPE OF CHILDBIRTH DELIVERY: ECONOMIC AND HEALTH IMPLICATION
Objective: Pregnancy is a critical period that can pose nutritional challenges, such as chronic energy deficiency and anemia, increasing maternal mortality risk. The World Health Organization recommends iron and folic acid supplements to mitigate these risks. This study compared labor types and associated costs between iron-folic acid (IFA) and multiple micronutrient (MMN) supplementations during pregnancy. Methods: An economic evaluation was conducted retrospectively at Semen Padang Hospital, analyzing data from January to December 2021. A total of 201 pregnant women were included, with 128 undergoing cesarean delivery. Cost data were collected from the hospital’s perspective and analyzed to identify differences between supplementation groups. Results: Total direct costs did not differ significantly between the IFA and MMN groups (p=0.82). However, medical costs varied substantially, with cesarean delivery costs being approximately 5 times higher than normal delivery costs. Conclusion: This study emphasizes the economic burden of cesarean deliveries compared to normal births and highlights the need for further evaluation of micronutrient supplementation’s cost-effectiveness. Findings advocate for policies that optimize maternal health outcomes and reduce delivery-related costs, addressing the high incidence of elective cesarean sections.
- Open Access
- 25 November 2024
- Published by Universitas Andalas in Jurnal Sains Farmasi & Klinis
- Vol. 11 (2) , 111-117
Comparative Economic and Clinical Utility of Adding Candesartan for Hypertension Management
Introduction: Antihypertensive drugs require high costs because they are used over a long period. Therefore, consideration is needed in drug selection requirements, effectiveness, and price. This study aimed to see the beneficial results of hypertension therapy and the non-medical costs incurred by patients using cost-utility analysis (CUA). Method: This research was a prospective study. The incremental Cost-Utility Ratio (ICUR) of antihypertensive treatment was calculated using cost-utility data obtained through EQ-5D-5L questionnaires from outpatients at Universitas Andalas Hospital in January- March 2023 who met the inclusion and exclusion criteria. The costs used were from a patient perspective, consisting of direct medical and non-medical costs. This study compared standard treatment (amlodipine) with the addition of candesartan. Results: The number of respondents in this study was 67, consisting of 23 respondents (34.33%) using amlodipine alone and 44 respondents (65.67%) using the amlodipine-candesartan combination. The ICUR value obtained was IDR7,318,674/QALY. The difference in the average utility value of the amlodipine-candesartan combination with amlodipine alone is -0.02, and the difference in cost is -IDR12,224. Based on the cost-utility diagram, the amlodipine-candesartan combination group is included in the southwest quadrant (quadrant III), which illustrates that the cost required for the amlodipine-candesartan combination group is lower than the cost of the amlodipine single treatment group and the outcome is also not better (slightly lower or the same). Conclusion: It was recommended to prioritize using amlodipine alone for hypertension management, as it provides similar outcomes to the amlodipine-candesartan combination while incurring lower costs.
- 25 November 2024
- Published by Universitas Andalas in Jurnal Sains Farmasi & Klinis
- Vol. 11 (2) , 111-117
Open AccessComparative Economic and Clinical Utility of Adding Candesartan for Hypertension Management
Introduction: Antihypertensive drugs require high costs because they are used over a long period. Therefore, consideration is needed in drug selection requirements, effectiveness, and price. This study aimed to see the beneficial results of hypertension therapy and the non-medical costs incurred by patients using cost-utility analysis (CUA). Method: This research was a prospective study. The incremental Cost-Utility Ratio (ICUR) of antihypertensive treatment was calculated using cost-utility data obtained through EQ-5D-5L questionnaires from outpatients at Universitas Andalas Hospital in January- March 2023 who met the inclusion and exclusion criteria. The costs used were from a patient perspective, consisting of direct medical and non-medical costs. This study compared standard treatment (amlodipine) with the addition of candesartan. Results: The number of respondents in this study was 67, consisting of 23 respondents (34.33%) using amlodipine alone and 44 respondents (65.67%) using the amlodipine-candesartan combination. The ICUR value obtained was IDR7,318,674/QALY. The difference in the average utility value of the amlodipine-candesartan combination with amlodipine alone is -0.02, and the difference in cost is -IDR12,224. Based on the cost-utility diagram, the amlodipine-candesartan combination group is included in the southwest quadrant (quadrant III), which illustrates that the cost required for the amlodipine-candesartan combination group is lower than the cost of the amlodipine single treatment group and the outcome is also not better (slightly lower or the same). Conclusion: It was recommended to prioritize using amlodipine alone for hypertension management, as it provides similar outcomes to the amlodipine-candesartan combination while incurring lower costs.
- Open Access
- 7 September 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 90-98
METALLOPROTEIN PARAMETERS IN MOLECULAR DYNAMICS SIMULATION FOR AMBER, CHARMM, GROMACS, AND NAMD: A SYSTEMATIC REVIEW
Objective: The selection of appropriate metal parameters for molecular dynamics simulations is a significant challenge. Therefore, this review aims to provide in-depth insights valuable for the optimization of parameter selection in the context of chemical simulations. Methods: A total of 550 scientific articles were collected from pubmed and science direct databases from 2009 to 2024, resulting in the inclusion of 60 full studies for review. The selection process of preferred reporting items for systematic reviews and meta-analyses (PRISMA) was utilized, enabling the conduction of an initial screening of articles by use of the Rayyan web-based application. Results: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. The Bonded Model incorporates MCPB, a Python-based software that facilitates parameter construction for over 80 metal ions and force fields in molecular dynamics simulations. The non-bonded model evaluates metals in proteins, such as zinc, nickel, magnesium, cobalt, iron, and cadmium by using AMBER force field and the Seminario method. The 12-6 lennard-Jones (LJ) non-bonded model is suitable for divalent, trivalent, and tetravalent metals, with Zinc parameters being compared for accuracy. Additionally, the force fields suitable for modeling unbound metal proteins include AMBER FF19SB, FF14SB, ff9X, CHARMM36, CHARMM22, CHARMM27, and CHARMM-Metal. Conclusion: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. molecular dynamics (MD) simulations can be conducted using various methods, such as classical molecular dynamics, umbrella sampling, quantum mechanics-discrete molecular dynamics (QM/DMD), stochastic boundary molecular dynamics (SBMD), steered molecular dynamics (SMD), gaussian accelerated molecular dynamics (GaMD) and random acceleration molecular dynamics (RAMD).
- 7 September 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 90-98
Open AccessMETALLOPROTEIN PARAMETERS IN MOLECULAR DYNAMICS SIMULATION FOR AMBER, CHARMM, GROMACS, AND NAMD: A SYSTEMATIC REVIEW
Objective: The selection of appropriate metal parameters for molecular dynamics simulations is a significant challenge. Therefore, this review aims to provide in-depth insights valuable for the optimization of parameter selection in the context of chemical simulations. Methods: A total of 550 scientific articles were collected from pubmed and science direct databases from 2009 to 2024, resulting in the inclusion of 60 full studies for review. The selection process of preferred reporting items for systematic reviews and meta-analyses (PRISMA) was utilized, enabling the conduction of an initial screening of articles by use of the Rayyan web-based application. Results: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. The Bonded Model incorporates MCPB, a Python-based software that facilitates parameter construction for over 80 metal ions and force fields in molecular dynamics simulations. The non-bonded model evaluates metals in proteins, such as zinc, nickel, magnesium, cobalt, iron, and cadmium by using AMBER force field and the Seminario method. The 12-6 lennard-Jones (LJ) non-bonded model is suitable for divalent, trivalent, and tetravalent metals, with Zinc parameters being compared for accuracy. Additionally, the force fields suitable for modeling unbound metal proteins include AMBER FF19SB, FF14SB, ff9X, CHARMM36, CHARMM22, CHARMM27, and CHARMM-Metal. Conclusion: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. molecular dynamics (MD) simulations can be conducted using various methods, such as classical molecular dynamics, umbrella sampling, quantum mechanics-discrete molecular dynamics (QM/DMD), stochastic boundary molecular dynamics (SBMD), steered molecular dynamics (SMD), gaussian accelerated molecular dynamics (GaMD) and random acceleration molecular dynamics (RAMD).